Ligand id: 8318

Name: venetoclax

Structure and Physico-chemical Properties

2D Structure
Click here for structure editor
Calculated Physico-chemical Properties
Hydrogen bond acceptors 9
Hydrogen bond donors 3
Rotatable bonds 14
Topological polar surface area 180.41
Molecular weight 867.32
XLogP 9.38
No. Lipinski's rules broken 2

Molecular properties generated using the CDK

Immunopharmacology Comments
Bcl-2, is an antiapoptotic protein that is central to the survival of chronic lymphocytic leukemia cells in which it is often pathologically overexpressed. Venetoclax inhibits this antiapoptotic functionality and restores apoptotic balance, which leads to tumour cell death.
Immunopharmacology Disease
Disease X-Refs Comment References
Asthma Disease Ontology: DOID:2841
OMIM: 600807
Venetoclax (ABT-199) has been shown to induce apoptosis of airway inflammatory cells (eosinophils, neutrophils, Th2, Th17 and dendritic cells) suggesting a potiential role in management of eosinophilic or corticosteroid resistant-neutrophilic airway inflammation. 5
Chronic lymphocytic leukemia Disease Ontology: DOID:1040
OMIM: 151400
Orphanet: ORPHA67038
Approved drug for CLL with or without 17p deletion. 2